##gff-version 3
##sequence-region Q9BSJ6 1 248
Q9BSJ6	UniProtKB	Chain	1	248	.	.	.	ID=PRO_0000281159;Note=Protein PIMREG	
Q9BSJ6	UniProtKB	Motif	14	17	.	.	.	Note=D-box 1	
Q9BSJ6	UniProtKB	Motif	53	56	.	.	.	Note=D-box 2	
Q9BSJ6	UniProtKB	Modified residue	11	11	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9BSJ6	UniProtKB	Modified residue	16	16	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163	
Q9BSJ6	UniProtKB	Modified residue	129	129	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q9BSJ6	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphoserine%3B by UHMK1%3B in vitro;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:20068231,ECO:0000269|PubMed:23419774;Dbxref=PMID:20068231,PMID:23419774	
Q9BSJ6	UniProtKB	Modified residue	199	199	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9BSJ6	UniProtKB	Modified residue	201	201	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9BSJ6	UniProtKB	Alternative sequence	229	248	.	.	.	ID=VSP_023997;Note=In isoform 2. RKQALSDRQGFILKDVYASP->SGDIVSLIHD;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q9BSJ6	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_056873;Note=S->C;Dbxref=dbSNP:rs16955870	
Q9BSJ6	UniProtKB	Mutagenesis	14	17	.	.	.	Note=Weak reduction in ubiquitination. Complete loss of ubiquitination%3B when associated with 53-A--A-56. RRSL->ARSA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18757745;Dbxref=PMID:18757745	
Q9BSJ6	UniProtKB	Mutagenesis	53	56	.	.	.	Note=Great reduction in ubiquitination. Complete loss of ubiquitination%3B when associated with 14-A--A-17. RLPL->ALPA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18757745;Dbxref=PMID:18757745	
Q9BSJ6	UniProtKB	Mutagenesis	129	129	.	.	.	Note=No effect on phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23419774;Dbxref=PMID:23419774	
Q9BSJ6	UniProtKB	Mutagenesis	131	131	.	.	.	Note=Reduced phosphorylation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23419774;Dbxref=PMID:23419774	
Q9BSJ6	UniProtKB	Sequence conflict	58	58	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9BSJ6	UniProtKB	Sequence conflict	167	167	.	.	.	Note=M->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
